Biktarvy, formally known as bictegravir, is a powerful single-tablet regimen for managing HIV infection. This formula unites three essential antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the virus's ability to multiply within the body, considerably decreasing the viral load. For many individuals,